About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Beatriz Villafranca Magdalena, Biomedical Research in Gynaecology Vall Hebron Institut de Recerca (VHIR)
Mortality in patients with high-risk and recurrent endometrial cancer is high since treatment options are limited, and tumors are extremely chemoresistant. In this study, we want to unveil the possible impact of molecular ITH on treatment response in endometrial cancer through a genomic study of PDX models developed from different areas of the tumor, the association of drugs targeting homogeneous and heterogeneous genomic alterations, and the preclinical study of those drugs in patient-derived xenograft organoid (PDXOs) models.
Brief CV. I studied Biochemistry and Molecular Biology at Rovira i Virgili University (Tarragona) and a Neuroscience master at University of Barcelona. Currently, I am doing the PhD in the Group of Biomedicine research in Ginecology lead by Dr. Eva Colás and Dr. Antonio Gil.
Host: Dr. Eva Colás Main researcher Biomedical Research in Gynaecology, Vall Hebron Institut de Recerca (VHIR)
